Greg Swan

home / authors / greg-swan

Greg Swan is business development manager, cell & gene therapies, at Avantor.

Articles

Adeno-associated virus. AAV virus genome. Adenoviral pneumonia, arthritis, bronchitis, hepatitis, cystitis. Adenovirus as vectors for gene therapy. Genetic material transmission to cell. Biotech 3D | Image Credit: © Corona Borealis - © Corona Borealis - stock.adobe.com

Improving Vector Yield at Scale: A Fresh Approach to Cell Lysis Quality Assessment

Greg Swan;Beth Kroeger-Fahnestock

December 26th 2024

Optimizing the harvest of viral particles is important for the yield and purity of the final product.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

Published: December 9th 2024 | Updated: December 27th 2024

Recap Key Industry Trends for Viral Clearance and NGS

Shining Pro - Stock.Adobe.com

Published: December 7th 2024 | Updated: December 27th 2024

Enhancing Quality Through Training

Published: July 20th 2020 | Updated: December 27th 2024

Contact BioPharm International Editors

Published: July 19th 2020 | Updated: December 27th 2024

Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.